Furthermore, EGFR loss induced G2/M phase arrest and resulted in an increased resistance to TNF-related apoptosis-inducing ligand (TRAIL) in renal cell carcinoma. Here, TNFSF10 is linked to hereditary clear cell renal cell carcinoma.